Although many studies have been done on the prognostic significance of counteracting Bcl-2 and Bax proteins, most of them failed to find a significant relationship between Bcl-2 expression levels and clinicopathological parameters of colorectal cancer. This evidence concerns the gene BCL2 and colorectal cancer.